Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

AIDS/HIV

U.N. Report: Over Half of People with HIV Having Treatment for First Time

London, September 15, 2017 — The Associated Press’ Maria Cheng reported in July that, for the first time in the global AIDS epidemic that has spanned four decades and killed 35 million people, more than half of all those infected with HIV are on drugs to treat the virus, the United Nations said in a report released Thursday.

AIDS deaths are also now close to half of what they were in 2005, according to the U.N. AIDS agency, although those figures are based on estimates and not actual counts from countries.

Experts applauded the progress, but questioned if the billions spent in the past two decades should have brought more impressive results. The U.N. report was released in Paris where an AIDS meeting begins this weekend. Continue reading

Richard Marlink, Known Globally for Work Fighting AIDS, to Lead Rutgers’ Global Health Institute

Dr. Richard Marlink

Dr. Richard Marlink

New Brunswick, May 3, 2016 ― Richard G. Marlink, M.D., a Harvard professor recognized internationally for research and leadership in the fight against AIDS, will join Rutgers as the inaugural Henry Rutgers Professor of Global Health and director of a new Global Health Institute at Rutgers Biomedical and Health Sciences (RBHS).

At the start of the AIDS epidemic, Marlink was instrumental in setting up the first HIV/AIDS clinic in Boston and studied the impact of the HIV virus in west and central Africa.

After helping to start the Botswana-Harvard Partnership in 1996, he founded the Kitso AIDS Training Program, which would become Botswana’s national AIDS training program. Kitso means knowledge in the local Setswana language.

Marlink, the Bruce A. Beal, Robert L. Beal, and Alexander S. Beal Professor of the Practice of Public Health at Harvard’s T.H. Chan School of Public Health and executive director of the Harvard AIDS Initiative, will join Rutgers in July, filling a key role in the strategic growth of RBHS: broadening the university’s presence in public health community efforts to improve health and wellness. Continue reading

February 7 Is 16th Annual National Black HIV/AIDS Awareness Day; NJ Department of Health Provides Resources

AIDS Red RobbonTrenton, NJ, February 5, 2016 ― The New Jersey Department of Health (NJDOH) is marking the 16th annual National Black HIV Awareness Day on Feb. 7 by encouraging African American residents to protect themselves from HIV/AIDS and get involved in community initiatives that promote awareness.

On Feb. 5, New Jersey Department of Health Deputy Commissioner Dr. Arturo Brito and Connie Calisti-Meyers, Assistant Commissioner of the Division of HIV, STD and TB Services, will join local community leaders in Trenton at the Greater Mt. Zion Church to observe National Black HIV Awareness Day from 8:30 a.m. to 3 p.m.

Acting Health Commissioner Cathleen Bennett said, “New Jersey is an incredibly diverse state with more than one-fifth of our population foreign-born.  We know African Americans are disproportionately burdened by HIV, which is 100 percent preventable.” Continue reading

HINJ Launches ‘Value of Medical Innovation’ Portal; Focuses on Saving Lives — And Saving Money

VMINew Brunswick, NJ, September 29, 2015 ― The HealthCare Institute of New Jersey (HINJ) has updated its online portal at HINJ.org to present Value of Medical Innovation, a fact-driven, consumer-friendly digital library that delves into the myriad benefits of medical innovation, which saves lives — and saves money.

HINJ’s Value of Medical Innovation presents statistics from a number of resources, including the U.S. government, the Advanced Medical Technology Association (AdvaMed), the Biotechnology Organization (BIO), the Pharmaceutical Research and Manufacturers of America (PhRMA) and various medical research organizations. Continue reading